These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Injectable contraception. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1980 Dec; 14(6):1-3. PubMed ID: 12310087 [TBL] [Abstract][Full Text] [Related]
5. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. Harel Z; Biro FM; Kollar LM; Rauh JL J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897 [TBL] [Abstract][Full Text] [Related]
7. Not FDA-approved, but experts recommend Depo-Provera. Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458 [TBL] [Abstract][Full Text] [Related]
10. What is breast cancer risk with Depo-Provera? Contracept Technol Update; 1992 Jan; 13(1):15-6. PubMed ID: 12343459 [TBL] [Abstract][Full Text] [Related]
11. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
17. FDA gives final approval to Depo amid concerns over safety, cost and coercion. Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620 [TBL] [Abstract][Full Text] [Related]
18. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. Harel Z; Biro FM; Kollar LM J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688 [TBL] [Abstract][Full Text] [Related]